Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

288

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
HepatitisHepatitis C
Interventions
DRUG

Filibuvir

300 mg BID

DRUG

Filibuvir

600 mg BID

DRUG

Placebo

BID

Trial Locations (77)

1020

Pfizer Investigational Site, Brussels

1126

Pfizer Investigational Site, Budapest

1200

Pfizer Investigational Site, Brussels

2650

Pfizer Investigational Site, Edegem

3000

Pfizer Investigational Site, Leuven

4032

Pfizer Investigational Site, Debrecen

5600

Pfizer Investigational Site, Békéscsaba

5700

Pfizer Investigational Site, Gyula

7100

Pfizer Investigational Site, Haine-Saint-Paul

7400

Pfizer Investigational Site, Kaposvár

9000

Pfizer Investigational Site, Ghent

10021

Pfizer Investigational Site, New York

12157

Pfizer Investigational Site, Berlin

13285

Pfizer Investigational Site, Marseille

14004

Pfizer Investigational Site, Córdoba

19141

Pfizer Investigational Site, Philadelphia

20099

Pfizer Investigational Site, Hamburg

20246

Pfizer Investigational Site, Hamburg

22713

Pfizer Investigational Site, Durham

23249

Pfizer Investigational Site, Richmond

24146

Pfizer Investigational Site, Kiel

27710

Pfizer Investigational Site, Durham

28006

Pfizer Investigational Site, Madrid

28029

Pfizer Investigational Site, Madrid

28034

Pfizer Investigational Site, Madrid

28220

Pfizer Investigational Site, Majadahonda

32207

Pfizer Investigational Site, Jacksonville

32209

Pfizer Investigational Site, Jacksonville

32720

Pfizer Investigational Site, DeLand

32789

Pfizer Investigational Site, Winter Park

32803

Pfizer Investigational Site, Orlando

32809

Pfizer Investigational Site, Orlando

33143

Pfizer Investigational Site, South Miami

33604

Pfizer Investigational Site, Pessac

35033

Pfizer Investigational Site, Rennes

37205

Pfizer Investigational Site, Nashville

40237

Pfizer Investigational Site, Düsseldorf

41014

Pfizer Investigational Site, Seville

46202

Pfizer Investigational Site, Indianapolis

50937

Pfizer Investigational Site, Cologne

53105

Pfizer Investigational Site, Bonn

54511

Pfizer Investigational Site, Vandœuvre-lès-Nancy

60611

Pfizer Investigational Site, Chicago

70112

Pfizer Investigational Site, New Orleans

75571

Pfizer Investigational Site, Paris

77030

Pfizer Investigational Site, Houston

78234

Pfizer Investigational Site, San Antonio

80045

Pfizer Investigational Site, Aurora

80113

Pfizer Investigational Site, Englewood

84132

Pfizer Investigational Site, Salt Lake City

92037

Pfizer Investigational Site, La Jolla

92110

Pfizer Investigational Site, Clichy

92118

Pfizer Investigational Site, Coronado

92123

Pfizer Investigational Site, San Diego

92801

Pfizer Investigational Site, Anaheim

92802

Pfizer Investigational Site, Anaheim

94010

Pfizer Investigational Site, Créteil

95655

Pfizer Investigational Site, Mather

95814

Pfizer Investigational Site, Sacramento

95817

Pfizer Investigational Site, Sacramento

02114-2622

Pfizer Investigational Site, Boston

T5H 3V9

Pfizer Investigational Site, Edmonton

T5H 4B9

Pfizer Investigational Site, Edmonton

T6G 2B7

Pfizer Investigational Site, Edmonton

V5Z 1M9

Pfizer Investigational Site, Vancouver

V6Z2C7

Pfizer Investigational Site, Vancouver

B3H 1V7

Pfizer Investigational Site, Halifax

B3H 2Y9

Pfizer Investigational Site, Halifax

H2L 4P9

Pfizer Investigational Site, Montreal

H2X 2P4

Pfizer Investigational Site, Montreal

H3A 1A1

Pfizer Investigational Site, Montreal

00927

Pfizer Investigational Site, Rio Piedras

110-744

Pfizer Investigational Site, Seoul

120-752

Pfizer Investigational Site, Seoul

135-710

Pfizer Investigational Site, Seoul

08003

Pfizer Investigational Site, Barcelona

08035

Pfizer Investigational Site, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY